126 related articles for article (PubMed ID: 6767846)
1. Structure--activity relationships in a series of novel 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylic acid antiallergy agents.
Althuis TH; Kadin SB; Czuba LJ; Moore PF; Hess HJ
J Med Chem; 1980 Mar; 23(3):262-9. PubMed ID: 6767846
[TBL] [Abstract][Full Text] [Related]
2. Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.
Althuis TH; Moore PF; Hess HJ
J Med Chem; 1979 Jan; 22(1):44-8. PubMed ID: 106118
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids.
Wade JJ; Erickson EH; Hegel RF; Lappi LR; Rice TK
J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M
J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acids. 1.
Erickson EH; Lappi LR; Rice TK; Swingle KF; Van Winkle M
J Med Chem; 1978 Sep; 21(9):984-8. PubMed ID: 722763
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agents.
Temple DL; Yevich JP; Covington RR; Hanning CA; Seidehamel RJ; Mackey HK; Bartek MJ
J Med Chem; 1979 May; 22(5):505-10. PubMed ID: 88521
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles.
Ager IR; Barnes AC; Danswan GW; Hairsine PW; Kay DP; Kennewell PD; Matharu SS; Miller P; Robson P; Rowlands DA
J Med Chem; 1988 Jun; 31(6):1098-115. PubMed ID: 2897466
[TBL] [Abstract][Full Text] [Related]
9. Quinoline derivatives as antiallergy agents. 2. Fused-ring quinaldic acids.
Hall CM; Wright JB; Johnson HG; Taylor AJ
J Med Chem; 1977 Oct; 20(10):1337-43. PubMed ID: 903921
[TBL] [Abstract][Full Text] [Related]
10. N,N'-(Phenylene)dioxamic acids and their esters as antiallergy agents.
Wright JB; Hall CM; Johnson HG
J Med Chem; 1978 Sep; 21(9):930-5. PubMed ID: 102796
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
Yamada N; Takahashi K; Endoh K; Arai Y
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
[TBL] [Abstract][Full Text] [Related]
12. Antiallergic and cytoprotective activity of new N-phenylbenzamido acid derivatives.
Makovec F; Peris W; Revel L; Giovanetti R; Redaelli D; Rovati LC
J Med Chem; 1992 Oct; 35(20):3633-40. PubMed ID: 1433173
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
Spicer BA; Ross JW; Smith H
Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
[TBL] [Abstract][Full Text] [Related]
15. Antiallergy activity of 10-oxo-10-H-pyridazino[6,1-b]quinazoline-2-carboxylic acids.
Schwender CF; Sunday BR; Kerbleski JJ; Herzig DJ
J Med Chem; 1980 Aug; 23(8):964-6. PubMed ID: 7401122
[TBL] [Abstract][Full Text] [Related]
16. Antiallergy activity of substituted 11-oxo-11 H-pyrido[2,1-b]quinazoline-8-carboxylic acids.
Schwender CF; Sunday BR; Herzig DJ; Kusner EK; Schumann PR; Gawlak DL
J Med Chem; 1979 Jun; 22(6):748-50. PubMed ID: 88523
[TBL] [Abstract][Full Text] [Related]
17. Selected immunologic properties of tiprinast, a non-steroidal antiallergy agent.
Gillespie E; Dungan KW; Gomoll AW; Seidehamel RJ
Int J Immunopharmacol; 1985; 7(5):655-60. PubMed ID: 2412976
[TBL] [Abstract][Full Text] [Related]
18. N-(4-Isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents.
Chiarino D; Grancini G; Frigeni V; Biasini I; Carenzi A
J Med Chem; 1991 Feb; 34(2):600-5. PubMed ID: 1899891
[TBL] [Abstract][Full Text] [Related]
19. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
20. (2-Carboxy-1,4-dihydro-4-oxoquinolyl)oxamic acids and (2-carboxy-1,4-dihydro-4-oxobenzo[h]quinolyl)oxamic acids as antiallergy agents.
Wright JB; Johnson HG
J Med Chem; 1977 Jan; 20(1):166-9. PubMed ID: 833818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
